301103 何氏眼科
2026/06 - 中期2025/122024/122023/122022/12

盈利能力分析
净资产收益率 ROE (%)2.1891.453-1.3852.9912.022
总资产报酬率 ROA (%)1.8951.241-1.1642.4971.618
投入资产回报率 ROIC (%)1.9841.300-1.2242.6221.712

边际利润分析
销售毛利率 (%)42.99340.98738.60741.76038.401
营业利润率 (%)10.0505.3220.5628.9997.446
息税前利润/营业总收入 (%)9.7675.395-0.5287.5926.635
净利润/营业总收入 (%)7.0732.417-3.2204.8763.361

收益指标分析
经营活动净收益/利润总额(%)88.62777.928178.35293.39393.122
价值变动净收益/利润总额(%)11.66025.78588.8903.0061.573
营业外收支净额/利润总额(%)-2.087-3.779-278.603-1.2160.578

偿债能力分析
流动比率 (X)9.3588.9918.3098.94311.877
速动比率 (X)8.8518.5437.8668.51511.373
资产负债率 (%)13.19713.63415.53516.56216.507
带息债务/全部投入资本 (%)2.9693.1343.0752.9252.195
股东权益/带息债务 (%)3,056.8982,886.5032,881.5483,011.6003,974.165
股东权益/负债合计 (%)657.621633.276543.748504.507505.374
利息保障倍数 (X)-127.19420.2280.781-5.844-7.769

营运能力分析
应收账款周转天数 (天)9.68511.33514.50512.59011.727
存货周转天数 (天)41.41341.40642.92044.19848.019